Login / Signup

XPO7 is a tumor suppressor regulating p21CIP1-dependent senescence.

Andrew J InnesBin SunVerena WagnerSharon BrookesDomhnall McHughJoaquim PomboRosa María PorrecaGopuraja DharmalingamSantiago VerniaJohannes ZuberJean Baptiste VannierRamon Garcia-EscuderoJesús Gil
Published in: Genes & development (2021)
Senescence is a key barrier to neoplastic transformation. To identify senescence regulators relevant to cancer, we screened a genome-wide shRNA library. Here, we describe exportin 7 (XPO7) as a novel regulator of senescence and validate its function in telomere-induced, replicative, and oncogene-induced senescence (OIS). XPO7 is a bidirectional transporter that regulates the nuclear-cytoplasmic shuttling of a broad range of substrates. Depletion of XPO7 results in reduced levels of TCF3 and an impaired induction of the cyclin-dependent kinase inhibitor p21CIP1 during OIS. Deletion of XPO7 correlates with poorer overall survival in several cancer types. Moreover, depletion of XPO7 alleviated OIS and increased tumor formation in a mouse model of liver cancer. Our results suggest that XPO7 is a novel tumor suppressor that regulates p21CIP1 expression to control senescence and tumorigenesis.
Keyphrases